BCL2 and granular cell tumor: In conclusion, cisplatin treatment under the influence of CM from fibroblasts and endothelial cells led to deregulation of genes involved in ‘post‐’ (TP53, BCL2, BCLXL) and ‘off‐target’ (ERBB2) resistance mechanisms in most analyzed GCT cell lines.